Previous 10 | Next 10 |
Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q4 2020 Earnings Call Nov 13, 2020 , 10:00 a.m. ET Operator Continue reading For further details see: Meridian Bioscience Inc (VIVO) Q4 2020 Earnings Call Transcript
Meridian Bioscience ([[VIVO]] +13.7%) Q4 results:Revenues: $64.2M (+26.0%); Life Science: $34.4M (+97.0%); Diagnostics $29.8M (-11.0%).Net Income: $6.5M (+58.5%); EPS: $0.15 (+50.0%); non-GAAP Net Income: $8.3M (+53.7%); non-GAAP EPS: $0.19 (+46.2%).Cash and equivalents was $53.5M.2021 Guidan...
The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Meridian Bioscience, Inc. 2020 Q4 - Results - Earnings Call Presentation
Meridian Bioscience (VIVO): Q4 Non-GAAP EPS of $0.19 beats by $0.05; GAAP EPS of $0.15 beats by $0.01.Revenue of $64.15M (+26.2% Y/Y) beats by $4.68M.Press Release For further details see: Meridian Bioscience EPS beats by $0.05, beats on revenue
CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020. Fourth Quarter 2020 Highlights (Comparison to Fourth Quarter Fiscal 2019): Consolidated N...
Company is hitting it out of the park in its Life Science segment. Market has already discounted this as we can see from the technical chart. We need to see improvement in Diagnostics soon to keep its present valuation. For further details see: Meridian Bioscience: Remai...
The best sectors to focus your attention on now. The highest-rated stocks worth adding to your watch list. Why high-volatility ahead of elections could create a great buy opportunity. For further details see: If Stocks Tumble On Election Worries, Here Are The Top Stocks ...
CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full year 2020 financial results Friday, November 13, 2020. Jack Kenny, Chief Executive Off...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. A list of cheap stocks. For further details see: Healthcare: XLV Survey For October
CINCINNATI, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has launched a complete solution improving the development of cancer diagnostic tests, allowing ...
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
The worldwide smartphone market has recently experienced a notable upturn in sales. October saw a 5% year-on-year growth, breaking a 27-...
Apple Inc. (NASDAQ:AAPL) has once again emerged as the most resilient smartphone maker in the world, reporting the slowest decline in iPhone shipme...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...